A Novel Clinical Consideration to Conserve Parenteral Fentanyl During the COVID-19 Pandemic

Anesth Analg. 2020 Nov;131(5):1355-1357. doi: 10.1213/ANE.0000000000005168.

Authors

Kyle T Herndon^{1

2}, Kate S Claussen^{1

3}, Jason J Braithwaite^{1

2}

Affiliations

¹ From the Department of Clinical Pharmacy, HealthTrust Purchasing Group.
² University of Tennessee College of Pharmacy.
³ Belmont University College of Pharmacy, Nashville, Tennessee.

PMID: 33079854
DOI: 10.1213/ANE.0000000000005168

No abstract available

MeSH terms

Administration, Cutaneous
Anesthetics, Intravenous / administration & dosage*
Anesthetics, Intravenous / pharmacokinetics
Anesthetics, Intravenous / supply & distribution*
COVID-19
Coronavirus Infections / diagnosis
Coronavirus Infections / epidemiology
Coronavirus Infections / therapy*
Coronavirus Infections / virology
Critical Illness
Delivery of Health Care*
Drug Compounding
Fentanyl / administration & dosage*
Fentanyl / pharmacokinetics
Fentanyl / supply & distribution*
Humans
Infusions, Intravenous
Pandemics
Pneumonia, Viral / diagnosis
Pneumonia, Viral / epidemiology
Pneumonia, Viral / therapy*
Pneumonia, Viral / virology
Respiration, Artificial* / adverse effects
Therapeutic Equivalency
Transdermal Patch

Substances

Anesthetics, Intravenous
Fentanyl